CircZNF609 inhibits miR-150-5p to promote high glucose-induced damage to retinal microvascular endothelial cells
Molecular and Cellular Endocrinology · 2024
DOI: 10.1016/j.mce.2024.112261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Jing Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Fifth Affiliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Endothelial Cells, Glucose, MicroRNAs. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Xinjiang Medical University.
Abstract (Originalsprache)
Hyperglycemia is a key contributor to diabetic macrovascular and ocular complications. It triggers a cascade of cellular damage, particularly in the retinal microvascular endothelial cells (RMECs). However, the underlying molecular mechanisms remain only partially understood. This study hypothesizes that CircZNF609 plays a pivotal role in mediating high glucose-induced damage in RMECs by modulating miR-150-5p and its downstream target genes, thereby affecting cellular survival, apoptosis, and oxidative stress. Gene expression datasets (GSE193974 and GSE160308) and clinical samples were used to investigate the expression levels of CircZNF609 and its interaction with miR-150-5p in the context of diabetic retinopathy (DR). Our results demonstrate that CircZNF609 is upregulated in both peripheral blood stem cells from DR patients and high glucose-stimulated hRMECs. Functional experiments reveal that silencing CircZNF609 improves cell viability, reduces apoptosis, inhibits tube formation, and modulates oxidative stress markers, whereas CircZNF609 overexpression exacerbates these effects. Moreover, miR-150-5p, a microRNA, was found to be negatively regulated by CircZNF609 and downregulated in DR. Its overexpression mitigates high glucose-induced cell injury. Our findings suggest a novel mechanism whereby CircZNF609 exacerbates high glucose-induced endothelial cell damage by sponging miR-150-5p, implicating the CircZNF609/miR-150-5p axis as a potential therapeutic target in diabetic retinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Fifth Affiliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical Universi…
- Department of Endocrinology, Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China.
- Department of Cardiology, Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China. Electronic address: 38204518@qq.com.
Förderung
- Xinjiang Medical University
Zitieren
APA
Gao, J., Wang, C., Zhang, J., Shawuti, Z., Wang, S., Ma, C., & Wang, J. (2024). CircZNF609 inhibits miR-150-5p to promote high glucose-induced damage to retinal microvascular endothelial cells. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112261
Vancouver
Gao J, Wang C, Zhang J, Shawuti Z, Wang S, Ma C, et al. CircZNF609 inhibits miR-150-5p to promote high glucose-induced damage to retinal microvascular endothelial cells. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112261
BibTeX
@article{Gao2024,
author = {Gao, Jing and Wang, Chenfei and Zhang, Jie and Shawuti, Zulifeiya and Wang, Siyao and Ma, Cunhua and Wang, Juan},
title = {CircZNF609 inhibits miR-150-5p to promote high glucose-induced damage to retinal microvascular endothelial cells},
journal = {Molecular and Cellular Endocrinology},
year = {2024},
doi = {10.1016/j.mce.2024.112261}
}
EUVIMED